Xenon Pharmaceuticals Inc.
HealthcareNASDAQ:XENE · NASDAQ Global Market
-$0.09 today
Vol 0.69M · Avg 1.22M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+59.04%
Period High
$62.76
Period Low
$30.30
Latest
$52.10
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Legend Biotech Corporation
NASDAQ:LEGN
$6.63B
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.15B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.47B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.29B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.25B
Travere Therapeutics, Inc.
NASDAQ:TVTX
$4.84B
Celcuity Inc.
NASDAQ:CELC
$4.32B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.40B
Zai Lab Limited
NASDAQ:ZLAB
$1.92B
Ascentage Pharma Group International
NASDAQ:AAPG
$409.04M
What is the latest XENE filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does XENE have?
Intrinsic Alpha currently shows 20 recent filings for XENE.
Explore More
Continue the stock analysis
Jump to another research area for this company.